about
Influence of a family history of type 2 diabetes, demographic and clinical data on carotid intima-media thickness in patients with type 1 diabetes: a cross-sectional study.Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats.Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.Dyslipidemia in young patients with type 1 diabetes mellitus.Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes.Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.Cardiovascular autonomic neuropathy.Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis.Insulin and Its Cardiovascular Effects: What Is the Current Evidence?GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress.Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT/GSK-3β/HIF-1α activation.Understanding the impact of hypoglycemia on the cardiovascular system.Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications.Body mass index as a risk factor for coronary events and mortality in patients with type 1 diabetes.Association between vascular health and ovarian ageing in type 1 diabetes mellitus.Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).Age at menopause in women with type 1 diabetes mellitus: the OVADIA studyIs subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
P2860
Q30828241-C1CE6897-F8A3-4CAF-8A1D-55149875B595Q33608846-84BBCF8B-8A55-44F4-BFA4-E0AB6B657CAEQ35249824-58B4A760-25E0-466A-BDA3-4689501CF9CBQ35685832-5885029F-A563-46AC-804A-5D8078156B09Q35794417-F4FA8852-8167-4CFF-95D6-182C68B569CFQ36503503-B826A9D9-FBFD-49F0-B91B-30FCDF541052Q37278065-415C8779-7F1F-45E7-9589-FF634148524CQ37710285-2EA59463-5655-49EA-983E-837402D10E26Q37711953-2CB9E1E0-C08A-4E74-9575-DB25453CFCC2Q38604382-F9BD3F88-20E1-4F99-BFF5-B8B759E49F99Q38737217-BB272B37-2230-4928-AEC1-2C62C29CD83FQ38813231-3FAC06A7-8DC9-406A-9C25-1C546ACA0BCEQ38980640-D579F1D6-3941-444E-A7F8-DE92F0CA560FQ39028912-8CD424AC-095C-43B2-8A9E-A4FC6B14EB95Q42517257-09F8D05C-445E-4685-BC63-CD13F1379143Q42555659-2ED63CF9-868F-4D4F-A306-DC252B26988CQ46452587-36359743-8B33-454E-A71F-B0EB94572EF7Q47160197-92C5035F-1C61-4734-AD6E-57D9405176FEQ48032836-788EB1B6-791A-470D-AA41-4201A0D7F7ADQ48129352-666F7748-05CE-462B-A975-39276720C6D5Q53128176-471A7007-B7A8-4373-992E-E4693FDBF81BQ55207460-48F7BD6C-96E3-40D5-A1FF-D8882B241411Q55240593-9E0133B1-77B7-4051-8ACC-DF9EFF0E96CDQ55260519-9C22C5DC-ACCF-4C2A-92B2-A40FFA2C59F5Q57910005-20719741-767A-4AB5-A682-C0E1EB73A31DQ58588491-DE0B0432-EAB7-47A8-B0AF-807F87DACE6D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type 1 diabetes and cardiovascular disease
@en
Type 1 diabetes and cardiovascular disease.
@nl
type
label
Type 1 diabetes and cardiovascular disease
@en
Type 1 diabetes and cardiovascular disease.
@nl
prefLabel
Type 1 diabetes and cardiovascular disease
@en
Type 1 diabetes and cardiovascular disease.
@nl
P2093
P2860
P356
P1476
Type 1 diabetes and cardiovascular disease
@en
P2093
Eberhard Standl
Francesco Cappuccio
Oliver Schnell
Paul Valensi
P2860
P2888
P356
10.1186/1475-2840-12-156
P407
P5008
P577
2013-10-28T00:00:00Z
P5875
P6179
1022892517